Milano, S.; Maqoud, F.; Rutigliano, M.; Saponara, I.; Carmosino, M.; Gerbino, A.; Lucarelli, G.; Battaglia, M.; Svelto, M.; Procino, G.
β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus. Int. J. Mol. Sci. 2023, 24, 1136.
https://doi.org/10.3390/ijms24021136
AMA Style
Milano S, Maqoud F, Rutigliano M, Saponara I, Carmosino M, Gerbino A, Lucarelli G, Battaglia M, Svelto M, Procino G.
β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus. International Journal of Molecular Sciences. 2023; 24(2):1136.
https://doi.org/10.3390/ijms24021136
Chicago/Turabian Style
Milano, Serena, Fatima Maqoud, Monica Rutigliano, Ilenia Saponara, Monica Carmosino, Andrea Gerbino, Giuseppe Lucarelli, Michele Battaglia, Maria Svelto, and Giuseppe Procino.
2023. "β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus" International Journal of Molecular Sciences 24, no. 2: 1136.
https://doi.org/10.3390/ijms24021136
APA Style
Milano, S., Maqoud, F., Rutigliano, M., Saponara, I., Carmosino, M., Gerbino, A., Lucarelli, G., Battaglia, M., Svelto, M., & Procino, G.
(2023). β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus. International Journal of Molecular Sciences, 24(2), 1136.
https://doi.org/10.3390/ijms24021136
